PPARGC1A and coronary artery disorder: A central question is whether reduced PGC1α and UCP1 mRNA expression in EAT is a prelude to the development of DM2 through a constitutively lower rate of β-oxidation and lower adipose activation, or a consequence of the diabetes itself, in either case leading to increased severity of CAD.